Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
May-2017 Volume 6 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2017 Volume 6 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review

Renal manifestations of primary mitochondrial disorders (Review)

  • Authors:
    • Josef Finsterer
    • Fulvio Scorza
  • View Affiliations / Copyright

    Affiliations: Neurological Department, Municipal Hospital Rudolfstiftung, A‑1030 Vienna, Austria, Paulista de Medicina School, Federal University of São Paulo, Primeiro Andar CEP, São Paulo 04039‑032, SP, Brazil
  • Pages: 487-494
    |
    Published online on: April 12, 2017
       https://doi.org/10.3892/br.2017.892
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present review was to summarize and discuss previous findings concerning renal manifestations of primary mitochondrial disorders (MIDs). A literature review was performed using frequently used databases. The study identified that primary MIDs frequently present as mitochondrial multiorgan disorder syndrome (MIMODS) at onset or in the later course of the MID. Occasionally, the kidneys are affected in MIDs. Renal manifestations of MIDs include renal insufficiency, nephrolithiasis, nephrotic syndrome, renal cysts, renal tubular acidosis, Bartter‑like syndrome, Fanconi syndrome, focal segmental glomerulosclerosis, tubulointerstitial nephritis, nephrocalcinosis, and benign or malign neoplasms. Among the syndromic MIDs, renal involvement has been most frequently reported in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke‑like episodes syndrome, Kearns‑Sayre syndrome, Leigh syndrome and mitochondrial depletion syndromes. Only in single cases was renal involvement also reported in chronic progressive external ophthalmoplegia, Pearson syndrome, Leber's hereditary optic neuropathy, coenzyme‑Q deficiency, X‑linked sideroblastic anemia and ataxia, myopathy, lactic acidosis, and sideroblastic anemia, pyruvate dehydrogenase deficiency, growth retardation, aminoaciduria, cholestasis, iron overload, lactacidosis, and early death, and hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis syndrome. The present study proposes that the frequency of renal involvement in MIDs is probably underestimated. Diagnosis of renal involvement follows general guidelines and treatment is symptomatic. Thus, renal manifestations of primary MIDs require recognition and appropriate management, as they determine the outcome of MID patients.
View Figures
View References

1 

Finsterer J: Inherited mitochondrial disorders. Adv Exp Med Biol. 942:187–213. 2012. View Article : Google Scholar : PubMed/NCBI

2 

McFarland R, Taylor RW and Turnbull DM: A neurological perspective on mitochondrial disease. Lancet Neurol. 9:829–840. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Finsterer J and Zarrouk-Mahjoub S: Mitochondrial Disorders May Mimic Amyotrophic Lateral Sclerosis at Onset. Sultan Qaboos Univ Med J. 16:e92–e95. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Emma F, Montini G, Parikh SM and Salviati L: Mitochondrial dysfunction in inherited renal disease and acute kidney injury. Nat Rev Nephrol. 12:267–280. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Niaudet P: Renal involvement in mitochondrial cytopathies. Nephrol Ther. 9:116–124. 2013.(In French). View Article : Google Scholar : PubMed/NCBI

6 

Emma F, Bertini E, Salviati L and Montini G: Renal involvement in mitochondrial cytopathies. Pediatr Nephrol. 27:539–550. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Seidowsky A, Hoffmann M, Glowacki F, Dhaenens CM, Devaux JP, de Sainte Foy CL, Provot F, Gheerbrant JD, Hummel A, Hazzan M, et al: Renal involvement in MELAS syndrome - a series of 5 cases and review of the literature. Clin Nephrol. 80:456–463. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Yokoyama J, Yamaguchi H, Shigeto H, Uchiumi T, Murai H and Kira J: A case of rhabdomyolysis after status epilepticus without stroke-like episodes in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Rinsho Shinkeigaku. 56:204–207. 2016.(In Japanese). View Article : Google Scholar : PubMed/NCBI

9 

Finsterer J and Frank M: Prevalence of neoplasms in definite and probable mitochondrial disorders. Mitochondrion. 29:31–34. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Motoda A, Kurashige T, Sugiura T, Nakamura T, Yamawaki T, Arihiro K and Matsumoto M: A case of MELAS with G13513A mutation presenting with chronic kidney disease long before stroke-like episodes. Rinsho Shinkeigaku. 53:446–451. 2013.(In Japanese). View Article : Google Scholar : PubMed/NCBI

11 

Ponzetto C, Bresolin N, Bordoni A, Moggio M, Meola G, Bet L, Prelle A and Scarlato G: Kearns-Sayre syndrome: Different amounts of deleted mitochondrial DNA are present in several autoptic tissues. J Neurol Sci. 96:207–210. 1990. View Article : Google Scholar : PubMed/NCBI

12 

Bresolin N, Moggio M, Bet L, Gallanti A, Prelle A, Nobile-Orazio E, Adobbati L, Ferrante C, Pellegrini G and Scarlato G: Progressive cytochrome c oxidase deficiency in a case of Kearns-Sayre syndrome: Morphological, immunological, and biochemical studies in muscle biopsies and autopsy tissues. Ann Neurol. 21:564–572. 1987. View Article : Google Scholar : PubMed/NCBI

13 

Emma F, Pizzini C, Tessa A, Di Giandomenico S, Onetti-Muda A, Santorelli FM, Bertini E and Rizzoni G: ‘Bartter-like’ phenotype in Kearns-Sayre syndrome. Pediatr Nephrol. 21:355–360. 2006. View Article : Google Scholar : PubMed/NCBI

14 

Berio A and Piazzi A: Kearns-Sayre syndrome associated with de Toni-Debré-Fanconi syndrome due to cytochrome-c-oxidase (COX) deficiency. Panminerva Med. 43:211–214. 2001.PubMed/NCBI

15 

Mochizuki H, Joh K, Kawame H, Imadachi A, Nozaki H, Ohashi T, Usui N, Eto Y, Kanetsuna Y and Aizawa S: Mitochondrial encephalomyopathies preceded by de-Toni-Debré-Fanconi syndrome or focal segmental glomerulosclerosis. Clin Nephrol. 46:347–352. 1996.PubMed/NCBI

16 

Mima A, Shiota F, Matsubara T, Iehara N, Akagi T, Abe H, Nagai K, Matsuura M, Murakami T, Kishi S, et al: An autopsy case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with intestinal bleeding in chronic renal failure. Ren Fail. 33:622–625. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Lederer SR, Klopstock T and Schiffl H: MELAS: A mitochondrial disorder in an adult patient with a renal transplant. Wien Klin Wochenschr. 122:363–365. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Lau KK, Yang SP, Haddad MN, Butani L and Makker SP: Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes syndrome with hypothyroidism and focal segmental glomerulosclerosis in a paediatric patient. Int Urol Nephrol. 39:941–946. 2007. View Article : Google Scholar : PubMed/NCBI

19 

Kubota H, Tanabe Y, Takanashi J and Kohno Y: Episodic hyponatremia in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS). J Child Neurol. 20:116–120. 2005. View Article : Google Scholar : PubMed/NCBI

20 

Cheong HI, Chae JH, Kim JS, Park HW, Ha IS, Hwang YS, Lee HS and Choi Y: Hereditary glomerulopathy associated with a mitochondrial tRNA(Leu) gene mutation. Pediatr Nephrol. 13:477–480. 1999. View Article : Google Scholar : PubMed/NCBI

21 

Iwasaki N, Babazono T, Tsuchiya K, Tomonaga O, Suzuki A, Togashi M, Ujihara N, Sakka Y, Yokokawa H, Ogata M, et al: Prevalence of A-to-G mutation at nucleotide 3243 of the mitochondrial tRNA(Leu(UUR)) gene in Japanese patients with diabetes mellitus and end stage renal disease. J Hum Genet. 46:330–334. 2001. View Article : Google Scholar : PubMed/NCBI

22 

Yanagihara C, Oyama A, Tanaka M, Nakaji K and Nishimura Y: An autopsy case of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome with chronic renal failure. Intern Med. 40:662–665. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Kurogouchi F, Oguchi T, Mawatari E, Yamaura S, Hora K, Takei M, Sekijima Y, Ikeda S and Kiyosawa K: A case of mitochondrial cytopathy with a typical point mutation for MELAS, presenting with severe focal-segmental glomerulosclerosis as main clinical manifestation. Am J Nephrol. 18:551–556. 1998. View Article : Google Scholar : PubMed/NCBI

24 

Piccoli GB, Bonino LD, Campisi P, Vigotti FN, Ferraresi M, Fassio F, Brocheriou I, Porpiglia F and Restagno G: Chronic kidney disease, severe arterial and arteriolar sclerosis and kidney neoplasia: On the spectrum of kidney involvement in MELAS syndrome. BMC Nephrol. 13:92012. View Article : Google Scholar : PubMed/NCBI

25 

Sangkhathat S, Kusafuka T, Yoneda A, Kuroda S, Tanaka Y, Sakai N and Fukuzawa M: Renal cell carcinoma in a pediatric patient with an inherited mitochondrial mutation. Pediatr Surg Int. 21:745–748. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Mori K, Narahara K, Ninomiya S, Goto Y and Nonaka I: Renal and skin involvement in a patient with complete Kearns-Sayre syndrome. Am J Med Genet. 38:583–587. 1991. View Article : Google Scholar : PubMed/NCBI

27 

Ho J, Pacaud D, Rakic M and Khan A: Diabetes in pediatric patients with Kearns-Sayre syndrome: Clinical presentation of 2 cases and a review of pathophysiology. Can J Diabetes. 38:225–228. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Liu HM, Tsai LP, Chien YH, Wu JF, Weng WC, Peng SF, Wu ET, Huang PH, Lee WT, Tsai IJ, et al: A novel 3670-base pair mitochondrial DNA deletion resulting in multi-systemic manifestations in a child. Pediatr Neonatol. 53:264–268. 2012. View Article : Google Scholar : PubMed/NCBI

29 

Tzoufi M, Makis A, Chaliasos N, Nakou I, Siomou E, Tsatsoulis A, Zikou A, Argyropoulou M, Bonnefont JP and Siamopoulou A: A rare case report of simultaneous presentation of myopathy, Addison's disease, primary hypoparathyroidism, and Fanconi syndrome in a child diagnosed with Kearns-Sayre syndrome. Eur J Pediatr. 172:557–561. 2013. View Article : Google Scholar : PubMed/NCBI

30 

Mihai CM, Catrinoiu D, Toringhibel M, Stoicescu RM and Hancu A: De Toni-Debré-Fanconi syndrome in a patient with Kearns-Sayre syndrome: A case report. J Med Case Reports. 3:1012009. View Article : Google Scholar

31 

Pitchon EM, Cachat F, Jacquemont S, Hinard C, Borruat FX, Schorderet DF, Morris MA and Munier FL: Patient with Fanconi Syndrome (FS) and retinitis pigmentosa (RP) caused by a deletion and duplication of mitochondrial DNA (mtDNA). Klin Monatsbl Augenheilkd. 224:340–343. 2007. View Article : Google Scholar : PubMed/NCBI

32 

Eviatar L, Shanske S, Gauthier B, Abrams C, Maytal J, Slavin M, Valderrama E and DiMauro S: Kearns-Sayre syndrome presenting as renal tubular acidosis. Neurology. 40:1761–1763. 1990. View Article : Google Scholar : PubMed/NCBI

33 

Katsanos KH, Elisaf M, Bairaktari E and Tsianos EV: Severe hypomagnesemia and hypoparathyroidism in Kearns-Sayre syndrome. Am J Nephrol. 21:150–153. 2001. View Article : Google Scholar : PubMed/NCBI

34 

Goto Y, Itami N, Kajii N, Tochimaru H, Endo M and Horai S: Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome. J Pediatr. 116:904–910. 1990. View Article : Google Scholar : PubMed/NCBI

35 

Choe Y, Park E, Hyun HS, Ko JM, Kang HG, Kim JH, Park SH and Cheong HI: A 7-year-old girl presenting with a Bartter-like phenotype: Answers. Pediatr Nephrol. (In press).

36 

Stojanovic V, Mayr JA, Sperl W, Barišić N, Doronjski A and Milak G: Infantile peripheral neuropathy, deafness, and proximal tubulopathy associated with a novel mutation of the RRM2B gene: Case study. Croat Med J. 54:579–584. 2013. View Article : Google Scholar : PubMed/NCBI

37 

De Greef E, Christodoulou J, Alexander IE, Shun A, O'Loughlin EV, Thorburn DR, Jermyn V and Stormon MO: Mitochondrial respiratory chain hepatopathies: Role of liver transplantation. A case series of five patients. JIMD Rep. 4:5–11. 2012. View Article : Google Scholar : PubMed/NCBI

38 

Prasad C, Melançon SB, Rupar CA, Prasad AN, Nunez LD, Rosenblatt DS and Majewski J: Exome sequencing reveals a homozygous mutation in TWINKLE as the cause of multisystemic failure including renal tubulopathy in three siblings. Mol Genet Metab. 108:190–194. 2013. View Article : Google Scholar : PubMed/NCBI

39 

Lee IC, Lee NC, Lu JJ and Su PH: Mitochondrial depletion causes neonatal-onset leigh syndrome, myopathy, and renal tubulopathy. J Child Neurol. 28:404–408. 2013. View Article : Google Scholar : PubMed/NCBI

40 

Kollberg G, Darin N, Benan K, Moslemi AR, Lindal S, Tulinius M, Oldfors A and Holme E: A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion. Neuromuscul Disord. 19:147–150. 2009. View Article : Google Scholar : PubMed/NCBI

41 

Acham-Roschitz B, Plecko B, Lindbichler F, Bittner R, Mache CJ, Sperl W and Mayr JA: A novel mutation of the RRM2B gene in an infant with early fatal encephalomyopathy, central hypomyelination, and tubulopathy. Mol Genet Metab. 98:300–304. 2009. View Article : Google Scholar : PubMed/NCBI

42 

Dimmock DP, Zhang Q, Dionisi-Vici C, Carrozzo R, Shieh J, Tang LY, Truong C, Schmitt E, Sifry-Platt M, Lucioli S, et al: Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat. 29:330–331. 2008. View Article : Google Scholar : PubMed/NCBI

43 

El-Hattab AW and Scaglia F: Mitochondrial DNA depletion syndromes: Review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics. 10:186–198. 2013. View Article : Google Scholar : PubMed/NCBI

44 

Yuri T, Kondo Y, Kohno K, Lei YC, Kanematsu S, Kuwata M, Iwasaka T and Tsubura A: An autopsy case of chronic progressive external ophthalmoplegia with renal insufficiency. Med Mol Morphol. 41:233–237. 2008. View Article : Google Scholar : PubMed/NCBI

45 

Majander A, Suomalainen A, Vettenranta K, Sariola H, Perkkiö M, Holmberg C and Pihko H: Congenital hypoplastic anemia, diabetes, and severe renal tubular dysfunction associated with a mitochondrial DNA deletion. Pediatr Res. 30:327–330. 1991. View Article : Google Scholar : PubMed/NCBI

46 

Singh V, Bhattacharjee S, Singh K and Narula MK: Leber's amaurosis with nephronophthisis and congenital hepatic fibrosis. Indian Pediatr. 41:1053–1056. 2004.PubMed/NCBI

47 

Furuyama K, Harigae H, Kinoshita C, Shimada T, Miyaoka K, Kanda C, Maruyama Y, Shibahara S and Sassa S: Late-onset X-linked sideroblastic anemia following hemodialysis. Blood. 101:4623–4624. 2003. View Article : Google Scholar : PubMed/NCBI

48 

Tay SK, Sacconi S, Akman HO, Morales JF, Morales A, De Vivo DC, Shanske S, Bonilla E and DiMauro S: Unusual clinical presentations in four cases of Leigh disease, cytochrome C oxidase deficiency, and SURF1 gene mutations. J Child Neurol. 20:670–674. 2005. View Article : Google Scholar : PubMed/NCBI

49 

Belostotsky R, Ben-Shalom E, Rinat C, Becker-Cohen R, Feinstein S, Zeligson S, Segel R, Elpeleg O, Nassar S and Frishberg Y: Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. Am J Hum Genet. 88:193–200. 2011. View Article : Google Scholar : PubMed/NCBI

50 

Gürgey A, Ozalp I, Rötig A, Coşkun T, Tekinalp G, Erdem G, Akeören Z, Caglar M and Bakkaloglu A: A case of Pearson syndrome associated with multiple renal cysts. Pediatr Nephrol. 10:637–638. 1996. View Article : Google Scholar : PubMed/NCBI

51 

Scalais E, Chafai R, Van Coster R, Bindl L, Nuttin C, Panagiotaraki C, Seneca S, Lissens W, Ribes A, Geers C, et al: Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2). Eur J Paediatr Neurol. 17:625–630. 2013. View Article : Google Scholar : PubMed/NCBI

52 

Rivera H, Martín-Hernández E, Delmiro A, García-Silva MT, Quijada-Fraile P, Muley R, Arenas J, Martín MA and Martínez-Azorín F: A new mutation in the gene encoding mitochondrial seryl-tRNA synthetase as a cause of HUPRA syndrome. BMC Nephrol. 14:1952013. View Article : Google Scholar : PubMed/NCBI

53 

Nakajima J, Eminoglu TF, Vatansever G, Nakashima M, Tsurusaki Y, Saitsu H, Kawashima H, Matsumoto N and Miyake N: A novel homozygous YARS2 mutation causes severe myopathy, lactic acidosis, and sideroblastic anemia 2. J Hum Genet. 59:229–232. 2014. View Article : Google Scholar : PubMed/NCBI

54 

Leslie N, Wang X, Peng Y, Valencia CA, Khuchua Z, Hata J, Witte D, Huang T and Bove KE: Neonatal multiorgan failure due to ACAD9 mutation and complex I deficiency with mitochondrial hyperplasia in liver, cardiac myocytes, skeletal muscle, and renal tubules. Hum Pathol. 49:27–32. 2016. View Article : Google Scholar : PubMed/NCBI

55 

Brecht M, Richardson M, Taranath A, Grist S, Thorburn D and Bratkovic D: Leigh Syndrome Caused by the MT-ND5 m.13513G>A Mutation: A Case Presenting with WPW-Like Conduction Defect, Cardiomyopathy, Hypertension and Hyponatraemia. JIMD Rep. 19:95–100. 2015. View Article : Google Scholar : PubMed/NCBI

56 

Yamakawa T, Yoshida F, Kumagai T, Watanabe H, Takano A, Mizuno M, Ikeguchi H, Morita Y, Sobue G and Matsuo S: Glomerulocystic kidney associated with subacute necrotizing-encephalomyelopathy. Am J Kidney Dis. 37:E142001. View Article : Google Scholar : PubMed/NCBI

57 

Kasapkara ÇS, Tümer L, Ezgü FS, Küçükçongar A and Hasanoğlu A: BCS1L gene mutation causing GRACILE syndrome: Case report. Ren Fail. 36:953–954. 2014. View Article : Google Scholar : PubMed/NCBI

58 

Levéen P, Kotarsky H, Mörgelin M, Karikoski R, Elmér E and Fellman V: The GRACILE mutation introduced into Bcs1l causes postnatal complex III deficiency: A viable mouse model for mitochondrial hepatopathy. Hepatology. 53:437–447. 2011. View Article : Google Scholar : PubMed/NCBI

59 

Viscomi C, Spinazzola A, Maggioni M, Fernandez-Vizarra E, Massa V, Pagano C, Vettor R, Mora M and Zeviani M: Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice. Hum Mol Genet. 18:12–26. 2009. View Article : Google Scholar : PubMed/NCBI

60 

Dabrowska A, Tarnowska C, Jałowinski R, Stankiewicz J and Grzegorz M: Multiple symmetric lipomatosis in the otolaryngology as diagnostic and therapeutic problem. Otolaryngol Pol. 59:717–722. 2005.(In Polish). PubMed/NCBI

61 

Yoshida I, Sweetman L, Kulovich S, Nyhan WL and Robinson BH: Effect of lipoic acid in a patient with defective activity of pyruvate dehydrogenase, 2-oxoglutarate dehydrogenase, and branched-chain keto acid dehydrogenase. Pediatr Res. 27:75–79. 1990. View Article : Google Scholar : PubMed/NCBI

62 

Uyama E, Kutsukake Y, Hara A, Uemura K, Uchino M, Mita S, Ando M and Taketomi T: Abnormal excretion of urinary phospholipids and sulfatide in patients with mitochondrial encephalomyopathies. Biochem Biophys Res Commun. 194:266–273. 1993. View Article : Google Scholar : PubMed/NCBI

63 

Doleris LM, Hill GS, Chedin P, Nochy D, Bellanne-Chantelot C, Hanslik T, Bedrossian J, Caillat-Zucman S, Cahen-Varsaux J and Bariety J: Focal segmental glomerulosclerosis associated with mitochondrial cytopathy. Kidney Int. 58:1851–1858. 2000. View Article : Google Scholar : PubMed/NCBI

64 

Menegon LF, Amaral TN and Gontijo JA: Renal sodium handling study in an atypical case of Bartter's syndrome associated with mitochondriopathy and sensorineural blindness. Ren Fail. 26:195–197. 2004. View Article : Google Scholar : PubMed/NCBI

65 

Valnot I, von Kleist-Retzow JC, Barrientos A, Gorbatyuk M, Taanman JW, Mehaye B, Rustin P, Tzagoloff A, Munnich A and Rötig A: A mutation in the human heme A:farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency. Hum Mol Genet. 9:1245–1249. 2000. View Article : Google Scholar : PubMed/NCBI

66 

Imasawa T, Tanaka M, Yamaguchi Y, Nakazato T, Kitamura H and Nishimura M: 7501 T > A mitochondrial DNA variant in a patient with glomerulosclerosis. Ren Fail. 36:1461–1465. 2014. View Article : Google Scholar : PubMed/NCBI

67 

Kobayashi A, Goto Y, Nagata M and Yamaguchi Y: Granular swollen epithelial cells: A histologic and diagnostic marker for mitochondrial nephropathy. Am J Surg Pathol. 34:262–270. 2010. View Article : Google Scholar : PubMed/NCBI

68 

de Lonlay P, Valnot I, Barrientos A, Gorbatyuk M, Tzagoloff A, Taanman JW, Benayoun E, Chrétien D, Kadhom N, Lombès A, et al: A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet. 29:57–60. 2001. View Article : Google Scholar : PubMed/NCBI

69 

Magner M, Dvorakova V, Tesarova M, Mazurova S, Hansikova H, Zahorec M, Brennerova K, Bzduch V, Spiegel R, Horovitz Y, et al: TMEM70 deficiency: Long-term outcome of 48 patients. J Inherit Metab Dis. 38:417–426. 2015. View Article : Google Scholar : PubMed/NCBI

70 

Riley LG, Rudinger-Thirion J, Schmitz-Abe K, Thorburn DR, Davis RL, Teo J, Arbuckle S, Cooper ST, Campagna DR, Frugier M, et al: LARS2 Variants Associated with Hydrops, Lactic Acidosis, Sideroblastic Anemia, and Multisystem Failure. JIMD Rep. 28:49–57. 2016. View Article : Google Scholar : PubMed/NCBI

71 

Saada A, Shaag A, Arnon S, Dolfin T, Miller C, Fuchs-Telem D, Lombes A and Elpeleg O: Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation. J Med Genet. 44:784–786. 2007. View Article : Google Scholar : PubMed/NCBI

72 

Tucker EJ, Wanschers BF, Szklarczyk R, Mountford HS, Wijeyeratne XW, van den Brand MA, Leenders AM, Rodenburg RJ, Reljić B, Compton AG, et al: Mutations in the UQCC1-interacting protein, UQCC2, cause human complex III deficiency associated with perturbed cytochrome b protein expression. PLoS Genet. 9:e10040342013. View Article : Google Scholar : PubMed/NCBI

73 

Gupta A, Colmenero I, Ragge NK, Blakely EL, He L, McFarland R, Taylor RW, Vogt J and Milford DV: Compound heterozygous RMND1 gene variants associated with chronic kidney disease, dilated cardiomyopathy and neurological involvement: A case report. BMC Res Notes. 9:3252016. View Article : Google Scholar : PubMed/NCBI

74 

D'Aco KE, Manno M, Clarke C, Ganesh J, Meyers KE and Sondheimer N: Mitochondrial tRNA(Phe) mutation as a cause of end-stage renal disease in childhood. Pediatr Nephrol. 28:515–519. 2013. View Article : Google Scholar : PubMed/NCBI

75 

Scaglia F, Vogel H, Hawkins EP, Vladutiu GD, Liu LL and Wong LJ: Novel homoplasmic mutation in the mitochondrial tRNATyr gene associated with atypical mitochondrial cytopathy presenting with focal segmental glomerulosclerosis. Am J Med Genet A. 123A:172–178. 2003. View Article : Google Scholar : PubMed/NCBI

76 

Matsumura M, Nakashima A, Araki T, Tofuku Y, Koizumi J, Yagi K, Koni I and Mabuchi H: L-Carnitine supplementation in a hemodialysis patient with a mutation in the mitochondrial tRNA(Leu(UUR)) gene. Nephron. 85:275–276. 2000. View Article : Google Scholar : PubMed/NCBI

77 

Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, Fang H, Song X, Cattran DC, Avila-Casado C, et al: ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest. 123:5179–5189. 2013. View Article : Google Scholar : PubMed/NCBI

78 

McDonald DG, McMenamin JB, Farrell MA, Droogan O and Green AJ: Familial childhood onset neuropathy and cirrhosis with the 4977bp mitochondrial DNA deletion. Am J Med Genet. 111:191–194. 2002. View Article : Google Scholar : PubMed/NCBI

79 

Broomfield A, Sweeney MG, Woodward CE, Fratter C, Morris AM, Leonard JV, Abulhoul L, Grunewald S, Clayton PT, Hanna MG, et al: Paediatric single mitochondrial DNA deletion disorders: An overlapping spectrum of disease. J Inherit Metab Dis. 38:445–457. 2015. View Article : Google Scholar : PubMed/NCBI

80 

Capková M, Tesarová M, Wenchich L, Cerná L, Hansíková H, Hůlková H, Hrubá E, Elleder M and Zeman J: Disorders of mitochondrial energy metabolism in patients with the Kearns-Sayre syndrome. Cas Lek Cesk. 141:51–54. 2002.(In Czech). PubMed/NCBI

81 

Löwik MM, Hol FA, Steenbergen EJ, Wetzels JF and van den Heuvel LP: Mitochondrial tRNALeu(UUR) mutation in a patient with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis. Nephrol Dial Transplant. 20:336–341. 2005. View Article : Google Scholar : PubMed/NCBI

82 

Tzen CY, Tsai JD, Wu TY, Chen BF, Chen ML, Lin SP and Chen SC: Tubulointerstitial nephritis associated with a novel mitochondrial point mutation. Kidney Int. 59:846–854. 2001. View Article : Google Scholar : PubMed/NCBI

83 

Tabebi M, Mkaouar-Rebai E, Mnif M, Kallabi F, Ben Mahmoud A, Ben Saad W, Charfi N, Keskes-Ammar L, Kamoun H, Abid M, et al: A novel mutation MT-COIII m.9267G>C and MT-COI m.5913G>A mutation in mitochondrial genes in a Tunisian family with maternally inherited diabetes and deafness (MIDD) associated with severe nephropathy. Biochem Biophys Res Commun. 459:353–360. 2015. View Article : Google Scholar : PubMed/NCBI

84 

Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, Chrétien D, de Lonlay P, Paquis-Flucklinger V, Arakawa H, et al: Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet. 39:776–780. 2007. View Article : Google Scholar : PubMed/NCBI

85 

Kanabus M, Shahni R, Saldanha JW, Murphy E, Plagnol V, Hoff WV, Heales S and Rahman S: Bi-allelic CLPB mutations cause cataract, renal cysts, nephrocalcinosis and 3-methylglutaconic aciduria, a novel disorder of mitochondrial protein disaggregation. J Inherit Metab Dis. 38:211–219. 2015. View Article : Google Scholar : PubMed/NCBI

86 

Distelmaier F, Haack TB, Catarino CB, Gallenmüller C, Rodenburg RJ, Strom TM, Baertling F, Meitinger T, Mayatepek E, Prokisch H, et al: MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset hypertrophic cardiomyopathy. Neurogenetics. 16:319–323. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Finsterer J and Scorza F: Renal manifestations of primary mitochondrial disorders (Review). Biomed Rep 6: 487-494, 2017.
APA
Finsterer, J., & Scorza, F. (2017). Renal manifestations of primary mitochondrial disorders (Review). Biomedical Reports, 6, 487-494. https://doi.org/10.3892/br.2017.892
MLA
Finsterer, J., Scorza, F."Renal manifestations of primary mitochondrial disorders (Review)". Biomedical Reports 6.5 (2017): 487-494.
Chicago
Finsterer, J., Scorza, F."Renal manifestations of primary mitochondrial disorders (Review)". Biomedical Reports 6, no. 5 (2017): 487-494. https://doi.org/10.3892/br.2017.892
Copy and paste a formatted citation
x
Spandidos Publications style
Finsterer J and Scorza F: Renal manifestations of primary mitochondrial disorders (Review). Biomed Rep 6: 487-494, 2017.
APA
Finsterer, J., & Scorza, F. (2017). Renal manifestations of primary mitochondrial disorders (Review). Biomedical Reports, 6, 487-494. https://doi.org/10.3892/br.2017.892
MLA
Finsterer, J., Scorza, F."Renal manifestations of primary mitochondrial disorders (Review)". Biomedical Reports 6.5 (2017): 487-494.
Chicago
Finsterer, J., Scorza, F."Renal manifestations of primary mitochondrial disorders (Review)". Biomedical Reports 6, no. 5 (2017): 487-494. https://doi.org/10.3892/br.2017.892
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team